Methadone lawsuits are, for the most part, disability-discrimination cases. People denied access to prescribed methadone or buprenorphine by jails, recovery programs, drug courts, hospitals, and state licensing schemes have sued under the Americans with Disabilities Act, Section 504 of the Rehabilitation Act, and in some cases the Fair Housing Act, and federal courts have largely sided with them. A smaller but distinct line of methadone litigation involves wrongful-death and malpractice claims tied to the drug’s unusual pharmacology, and a separate track of federal investigations and False Claims Act settlements targets alleged billing fraud at for-profit methadone clinic chains.
Below is where the main cases stand.
The Salvation Army Class Action
Tassinari v. The Salvation Army is the largest active methadone-related case. Filed May 14, 2021, in the U.S. District Court for the District of Massachusetts, it challenges the Salvation Army’s policy banning roughly 60 medications it labels “known to be abusive and addictive,” including methadone and buprenorphine, across its more than 140 Adult Rehabilitation Centers.1ClassAction.org. Class Action Alleges Salvation Army Discriminates Against Opioid Addicts Undergoing Doctor Prescribed Treatments Lead plaintiff Mark Tassinari alleges he was discharged from one Salvation Army facility in 2018 for using prescribed buprenorphine and refused entry at another in 2021 for the same reason.2STAT News. Addiction Treatment Medication Class Action Lawsuit Salvation Army
On March 26, 2025, Judge Leo Sorokin certified two classes: an injunctive-relief class covering people with opioid use disorder on prescribed methadone or buprenorphine who seek Salvation Army services, and a damages class of people whose records show they were discharged for taking the medication.3Altshuler Berzon. District Court Certifies Classes in Lawsuit Challenging the Salvation Army’s Policy The court approved a two-phase bench trial separating liability from damages.4FindLaw. Tassinari v. The Salvation Army, Class Certification Order No trial date has been publicly scheduled, and the case remains ongoing.5Civil Rights Litigation Clearinghouse. Tassinari v. The Salvation Army The complaint pleads the ADA, Section 504, and the Fair Housing Act.1ClassAction.org. Class Action Alleges Salvation Army Discriminates Against Opioid Addicts Undergoing Doctor Prescribed Treatments
Jail and Prison Cases
A line of jail cases has established that cutting incarcerated people off from prescribed methadone or buprenorphine likely violates both the ADA and the Eighth Amendment.
In Pesce v. Coppinger, filed in September 2018, Judge Denise Casper granted a preliminary injunction requiring Massachusetts’s Middleton House of Corrections to administer the plaintiff’s prescribed methadone, finding he was likely to succeed on his ADA and Eighth Amendment claims and that forced withdrawal would cause irreparable harm. The court later awarded $227,601 in attorney fees after finding him the prevailing party.6Civil Rights Litigation Clearinghouse. Pesce v. Coppinger
In Smith v. Aroostook County, the First Circuit affirmed on April 30, 2019, that Maine’s Aroostook County Jail likely violated the ADA when it refused to continue Brenda Smith’s prescribed buprenorphine, rejecting the argument that courts should defer broadly to correctional security concerns.7ACLU of Maine. Smith v. Aroostook County8NASADAD. Recent Court Actions Impacting SUD Field
In M.C. v. Jefferson County, a 2022 class action against an upstate New York jail, the court issued a class-wide preliminary injunction blocking a blanket ban on agonist medications. The case settled in March 2024, with final approval in August 2024. Under the consent decree, Jefferson County must allow continued prescribed medication, evaluate inmates without prescriptions at intake, and provide discharge planning for continuity of care. The county paid more than $350,000 to two former inmates, and the NYCLU receives three years of compliance data.9NYCLU. M.C. v. Jefferson County10NYCLU. Landmark Settlement Ends Forced Withdrawal Medical Treatment Opioid Addiction NY
The Department of Justice has moved on the same ground. In September 2024, it settled with the Mason County Jail in Washington State, requiring the facility to provide medical evaluations for opioid use disorder, offer all three FDA-approved medications (methadone, buprenorphine, and naltrexone), and report any discontinued medications every 180 days.11Prison Legal News. Washington Jail Settles DOJ Allegations ADA Noncompliance Failure Treat Opioid Use Disorder In December 2023, DOJ filed a statement of interest in Strickland v. Delaware County (Pennsylvania) arguing that the ADA bars categorical denials and requires individualized medical assessment.12U.S. Department of Justice. United States Files Statement of Interest to Prevent Discrimination and Ensure Access
Courts and Hospitals
In February 2022, the DOJ sued Pennsylvania’s Unified Judicial System, alleging drug court and supervision programs in several counties prohibited or limited participants from using prescribed medication for opioid use disorder. The system settled in January 2024, agreeing to pay $100,000 to affected individuals, encourage adoption of non-discrimination policies statewide, and train judges, probation officers, and treatment court coordinators. The agreement binds the system for two years.13U.S. Department of Justice. Justice Department Secures Agreement With Pennsylvania Courts14U.S. Department of Justice. United States v. Unified Judicial System of Pennsylvania
Hospitals have also been reached. In a 2020 settlement, the DOJ found that Massachusetts General Hospital violated the ADA by rejecting a 27-year-old cystic fibrosis patient, Bryan, for lung transplant eligibility because he was taking Suboxone, without consulting addiction specialists as the hospital’s own protocol required. MGH paid $170,000 to the patient and $80,000 to his mother, adopted a non-discrimination policy, and trained its transplant staff.15U.S. Department of Justice. Massachusetts General Hospital Settlement Agreement16STAT News. To Protect People With Addiction From Discrimination the Justice Dept Turns to the ADA
West Virginia’s Clinic Cap
The newest front is state licensing. On March 5, 2026, Solutions Oriented Addiction Response of West Virginia (SOAR-WV), represented by the ACLU, sued in U.S. District Court for the Southern District of West Virginia, arguing that the state’s cap of nine methadone clinics (in place since 2007) and a zoning ban on new clinics within a half-mile of schools or daycare centers violate Title II of the ADA and Section 504.17ACLU. Community Service Provider Files Federal Lawsuit to Overturn West Virginia’s Moratorium on Methadone Clinics The ACLU of West Virginia said at least 11,983 people have died from opioid overdoses in the state since the moratorium took effect.18ACLU of West Virginia. Community Service Provider Files Federal Lawsuit to Overturn Moratorium on Methadone Clinics
In April 2026, West Virginia Attorney General J.B. McCuskey moved to dismiss, arguing SOAR-WV lacks standing because it is neither a person with a disability nor an opioid treatment provider, and that federal law does not require the state to license additional clinics. The case is pending before Judge Robert Chambers.19West Virginia Watch. AG McCuskey Asks Judge to Dismiss Methadone Clinic Moratorium Lawsuit
Zoning Cases Against Cities
Local governments trying to block methadone clinics through zoning have repeatedly lost. The pattern across these cases is the same: when a zoning restriction singles out methadone treatment facilities and imposes requirements not applied to comparable medical services, courts have found it discriminates against people with a disability under the ADA.
- MX Group v. City of Covington (6th Cir. 2002): a moratorium on all substance use disorder treatment programs violated Title II; the Sixth Circuit rejected generalized fears about crime as a justification.20Legal Action Center. Overcoming Opposition to Substance Use Programs
- New Directions Treatment Services v. City of Reading (3d Cir. 2007): the Third Circuit struck down a Pennsylvania law banning methadone clinics within 500 feet of schools, playgrounds, parks, and residential areas as a violation of the ADA and Rehabilitation Act.21Public Interest Law Center. Methadone and Zoning
- BAART v. City of Antioch (1999): a 500-foot residential buffer was facially discriminatory under the ADA.20Legal Action Center. Overcoming Opposition to Substance Use Programs
- Habit Management v. City of Lynn (2002): a two-mile school buffer that effectively banned all methadone clinics in the city was ruled discriminatory.20Legal Action Center. Overcoming Opposition to Substance Use Programs
- RHJ Medical Center v. City of DuBois (W.D. Pa.): after a 2012 bench trial, the court found discriminatory zoning practices prevented operation of a clinic and awarded $132,800 in damages plus more than $270,000 in attorney fees.21Public Interest Law Center. Methadone and Zoning
Wrongful Death and Malpractice
A separate line of methadone litigation involves fatalities tied to dosing. Methadone has a long half-life that outlasts its pain-relief window, so it can accumulate and cause respiratory depression or cardiac arrhythmia, especially in patients not yet tolerant. Federal regulations cap the initial dose for new patients at 30 milligrams and require initial medical examinations and ongoing monitoring.22Attorney at Law Magazine. Methadone Clinic Liability23National Institutes of Health. Methadone Safety: A Clinical Practice Guideline
One illustrative Pennsylvania case involved the family of a 23-year-old patient who died of sudden cardiac arrest after being placed on a methadone and Valium taper at a rehabilitation facility. The family alleged the combination, together with low potassium, caused a fatal rhythm disturbance. After years of proceedings, including a state Supreme Court appeal of an initial nonsuit, a 12-person jury returned a defense verdict for all remaining defendants at a second trial in May 2021.24Rawle & Henderson. Nonsuit in Medical Malpractice Wrongful Death Case Reported verdicts are relatively rare because methadone malpractice claims frequently settle under seal.23National Institutes of Health. Methadone Safety: A Clinical Practice Guideline
Investigations Into For-Profit Clinic Chains
If you’ve seen news about methadone “lawsuits” that aren’t about discrimination, they’re usually about billing. In August 2025, Senator Maggie Hassan of New Hampshire opened an investigation into three large for-profit chains — Acadia Healthcare, BayMark Health Services, and New Season — citing reporting that Acadia had fabricated therapy notes to drive revenue and that BayMark required weekly patient visits regardless of clinical need to generate billing.25Senator Maggie Hassan. Senator Hassan Launches Investigation Into For-Profit Methadone Clinics26STAT News. Hassan Investigates For-Profit Methadone Clinics In April 2026, Hassan sent New Season a detailed letter alleging improper out-of-pocket drug-test charges to Medicaid patients, forced enrollment in intensive outpatient programs to maximize billing, and documenting 15-minute therapy sessions as hour-long encounters. She requested documents by May 14, 2026; the company had not publicly responded by that date.27New Hampshire Bulletin. In Letter Hassan Raises Concerns About Methadone Clinics Business Practices and Substandard Care
Acadia had already agreed in September 2024 to pay $19.85 million to settle DOJ allegations that it billed Medicare, Medicaid, and TRICARE for medically unnecessary inpatient behavioral health services between 2014 and 2017, resolving two whistleblower suits. The company did not admit liability.28U.S. Department of Justice. Acadia Healthcare Company Inc to Pay $19.85M to Settle Allegations
The Legal Theory Pulling It Together
Most methadone lawsuits rest on a single argument: opioid use disorder is a disability under federal law, and denying access to FDA-approved medication for that condition is discrimination. Title II of the ADA covers state and local government entities, including jails and courts. Section 504 of the Rehabilitation Act covers any entity receiving federal financial assistance. Housing and recovery-program cases often add the Fair Housing Act.
The DOJ has reinforced that framework through formal guidance titled “The Americans with Disabilities Act and the Opioid Crisis” and a series of enforcement actions. In 2022 alone, it issued findings or settlements involving the Indiana State Board of Nursing, a Massachusetts drug court, a Colorado job program, and the Pennsylvania court system.29U.S. Department of Justice. Justice Department Issues Guidance on Protections for People With Opioid Use Disorder Under the ADA
The consistent line from the courts is that an individualized medical assessment is required. Blanket bans on methadone or buprenorphine, justified by generalized concerns about diversion or abuse, don’t survive. That rule has now been applied to jails, courts, recovery housing, hospitals, employers, and child welfare agencies.30Legal Action Center. Cases Involving Denial of Access to MOUD
If you’re considering a claim, the pattern across the winning cases is worth noting: the plaintiff had a current prescription from a treating clinician, the institution applied a categorical rule rather than making an individual medical judgment, and the denial caused concrete harm — forced withdrawal, loss of housing or services, exclusion from a program, or worse. Those are the facts that have moved courts.